Solid Dosage
GEA supplies highly specialized solutions for manufacturing inhalable drugs ranging from dry powder blending, spray drying to particle engineering capabilities.
Inhalables and aerosols, no matter whether they are in liquid or solid form, must be delivered to the oral cavity or the greater respiratory system.
Inhalation is often the preferred drug delivery method for lung diseases, offering a number of advantages for both patients and medical professionals for the administration of vaccines and other biological drugs. Producing powders for inhalation is relatively straightforward on a small scale; but, it can be hard to replicate at a commercial level.
To facilitate the process, GEA has developed a highly specialized spray drying system that offers large-scale particle engineering capabilities. This makes it possible to accurately manipulate the aerodynamic size and flow properties of particles to produce fine, free-flowing powders for applications such as commercializing biological compounds including hormones, peptides and proteins that risk degradation if ingested.
When it comes to mixing and blending very fine powders, homogeneity and stability are key factors during the production of inhalable drugs. As such, GEA also offers production-scale mixing and blending solutions to produce inhalable products (dry powders and suspensions).
The TRV high-speed blender, a standalone PharmaConnect® module, is particularly suitable for the rapid batch blending of small quantities of APIs with base excipients. By combining the high surface area of the main impeller blade with the directional effects of the feeder blade, rapid, homogenous and stable blends can be produced in a reproducible manner.
Affichage de 4 sur 15
Contained Materials Handling solutions for Primary and Secondary Pharmaceuticals and Healthcare. With extensive experience within the generics sector, supply a wide range of technologies and equipment that improve and enhance the efficiency and performance of Oral Solid Dosage production.
The ConsiGma® DC for direct compression is the latest expansion of GEA's continuous portfolio for cost effective, compact, high yield manufacturing systems. It offers a robust and flexible manufacturing method for a wide range of products.
Continuous Processing is becoming more and more important in the pharmaceutical industry. GEA takes the lead in introducing this innovative technology with ConsiGma® - continuous high-shear granulation and drying lines.
At GEA we believe that continuous processing improves the quality of pharmaceutical end products: by focusing on quality during the whole product life-cycle, not just “tested in” quality; and by understanding the capability of your processes, managing sources of variability and decreasing any associated risks.
Le changement climatique et la croissance de la population mondiale exercent une pression accrue sur l’industrie alimentaire, grande consommatrice d’énergie, afin qu’elle nourrisse un plus grand nombre de personnes sans aggraver son impact sur la planète. George Shepherd, Global Technical Sustainability Manager de GEA, explique comment GEA met à profit son expertise en ingénierie pour aider les transformateurs à produire de manière plus durable tout en augmentant leur productivité.
The world's population is growing and with it demand for milk. Dairy is an essential component of many global diets. However, its production can be resource-intensive and impact the environment. GEA’s Christian Müller, Senior Director Sustainability Farm Technologies, sheds light on how technological innovations powered by GEA make milk production more efficient and profitable.
Chaque boisson, chaque aliment sûr est une victoire contre les menaces microbiennes invisibles, une bataille gagnée grâce à un siècle de conception de procédés hygiéniques. Avec plus de 100 ans de savoir-faire en matière d’ingénierie et de conception hygiénique, GEA dicte la norme pour les équipements de process, afin de protéger les denrées alimentaires et de sauver des vies.